<DOC>
	<DOCNO>NCT00344942</DOCNO>
	<brief_summary>To demonstrate superiority clinical efficacy 12 week ' treatment Nasacort versus placebo adult patient present Chronic Non Allergic Non Infectious Rhinitis</brief_summary>
	<brief_title>Efficacy Safety Study Nasacort Chronic Non Allergic Non Infectious Rhinitis Adults</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>patient present Chronic Non Allergic Non Infectious Rhinitis capable benefiting corticosteroid therapy administer via nasal route . patient chronic rhinitis minimum duration 12 week , whether consecutive , per year . patient Non Allergic Rhinitis confirm negative phadiatop test . patient present mean global score 5 symptom &gt; = 5 ( nasal obstruction , rhinorrhea , disturbance sense smell , sneeze , facial heaviness ) , mean score 3 main symptom ( nasal obstruction , rhinorrhea , disturbance sense smell ) &gt; = 5 ( mean 7 day prior visit V0 ) . patient present inflammation score anterior rhinoscopy nasal endoscopy &gt; = 4. patient present nasal polyp patient present severe septal deviation would interfere insertion nasal spray patient present nasal cavity tumor patient present sinus infection patient present history endonasal surgery patient present chronic rhinitis extrinsic origin ( drugrelated foodrelated rhinitis ) intrinsic origin ( hormonal rhinitis , positional rhinitis , atrophic rhinitis , ... ) patient program intensive sport train patient presenting : cystic fibrosis , pulmonary mycosis , necrotising vascularitis , immotile cilium syndrome , ... . patient present know immunosuppression , lymphoma patient present know cardiovascular , neurological medically significant illness patient present know renal failure , know glaucoma , know drug addiction current antibiotic therapy corticosteroid administer two month prior admission patient present problem haemostasis ( epistaxis ) , ophthalmic and/or orobucconasal herpetic infection . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>